A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season

scientific article published on 29 March 2016

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIW176
P932PMC publication ID4901864
P698PubMed publication ID27025838

P50authorMel KrajdenQ6810759
James A DickinsonQ42422634
Catharine ChambersQ57259188
Yan LiQ69032212
Nathalie BastienQ69032280
Gaston De SerresQ86870133
Jonathan B GubbayQ87716515
Steven J DrewsQ90185362
Alireza EshaghiQ94927841
Christine MartineauQ107855435
Danuta M. SkowronskiQ111259505
Suzana SabaiducQ114718265
Anne-Luise WinterQ114718267
Trijntje L KwindtQ114718277
P2860cites workVariable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesQ38803189
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.Q39961932
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season resultsQ40357312
Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccineQ40870040
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a virusesQ40935953
Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015.Q41442929
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.Q41474318
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.Q41543622
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolutionQ42253862
Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza seasonQ56767236
SWISS-MODEL: An automated protein homology-modeling serverQ24672647
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskQ27330166
FastTree 2--approximately maximum-likelihood trees for large alignmentsQ28748616
Mortality associated with influenza and respiratory syncytial virus in the United StatesQ29615578
Predicting the evolution of human influenza A.Q30011145
Estimating influenza deaths in Canada, 1992-2009.Q30356489
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Q30360290
Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.Q30377052
Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiariesQ30382515
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from CanadaQ30388012
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong KongQ30396064
Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in childrenQ30408006
Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009.Q30409721
Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza virusesQ30419865
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimatesQ33554684
Serologic assays for influenza surveillance, diagnosis and vaccine evaluationQ34194336
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasonsQ34393525
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewQ34778408
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesQ35130915
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus typeQ35531934
Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015Q35705382
Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibilityQ35715694
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza SeasonQ35805949
Variable efficacy of repeated annual influenza vaccinationQ36705674
Influenza vaccine effectiveness in the community and the householdQ36956943
Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United StatesQ36957563
Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccinesQ37208841
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.Q37568436
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza SeasonQ38415770
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectinfluenza vaccineQ383260
P304page(s)21-32
P577publication date2016-03-29
P1433published inClinical Infectious DiseasesQ5133764
P1476titleA Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season
P478volume63

Reverse relations

cites work (P2860)
Q384101592014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
Q400870982015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Q56991712A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Viruses
Q93089924A framework for research on vaccine effectiveness
Q99207892Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice
Q41932798Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada
Q49713969An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children
Q37591325Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time
Q90299458Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains
Q50065275Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness
Q47678684Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons
Q92915035Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort
Q64054477Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic
Q90131599Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018
Q90621783Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season
Q57471354Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection
Q47150783Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Q39215322Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera
Q93367325Diminished B-Cell Response After Repeat Influenza Vaccination
Q53283393Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
Q64130248Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016
Q30391150Effect of Statin Use on Influenza Vaccine Effectiveness
Q52689551Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
Q41932605Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Q38378102Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season
Q31161295Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies
Q98578103Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
Q40670577Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
Q58722425Estimating Vaccine-Driven Selection in Seasonal Influenza
Q61848787Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records
Q47363883Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016.
Q37681302Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study.
Q52805071Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17.
Q57022286Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong, China, 1996-2012
Q59349308Immune History and Influenza Vaccine Effectiveness
Q39088963Immune history and influenza virus susceptibility
Q59351989Immunizing the Immune: Can We Overcome Influenza's Most Formidable Challenge?
Q47564122Impact of seasonal influenza vaccination in the presence of vaccine interference
Q52315590Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
Q90858175Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season
Q49820109Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015.
Q47549841Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
Q30397977Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement
Q90246622Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease
Q40089214Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season
Q90255566Influenza outbreaks in Ontario hospitals, 2012-2016
Q40261504Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers
Q40068128Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season
Q54277492Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
Q55339340Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
Q52651633Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Seriou
Q59349704Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States
Q37652088Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
Q47413448Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Q37708550Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017
Q40280573Moving Toward Improved Influenza Vaccines
Q39422605Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
Q91898584Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal
Q41930762Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV).
Q53767227Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects.
Q90435489Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections
Q92526352Prior influenza vaccination effects on vaccine effectiveness: a point of consideration for health care workers
Q40152643Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States
Q37422072Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
Q64130675Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses
Q40280348Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza
Q39340731Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
Q38678530Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
Q40146222Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
Q30151372Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
Q57100141Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
Q40248207The Doctrine of Original Antigenic Sin: Separating Good From Evil
Q47700569The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia
Q41919202The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine
Q90745138The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid
Q90692852The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q47136504The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.
Q50453718The evolution of seasonal influenza viruses
Q96813808The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus
Q38639994The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q60912426The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
Q94568355Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies
Q90423467Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol

Search more.